| http://www.w3.org/ns/prov#value | - While details of the European Medicine Agencies letter (EMEA) have not been released, the news is a further blow for the facility following a number of regulatory problems over the last few months.In March, the US Food and Drug Administration (FDA) said it had found ???significant objectionable conditions??? at the plant, including several deviations from current good manufacturing (cGMP) practice
|
